LABT· Health Care› Biotechnology

Lakewood-Amedex Biotherapeutics Inc.

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. More about the company

$0.49

+4.26% today

$1.2M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

Steady

Edge

—

Is LABT early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2026-04-23 → 2026-10-22

S? 26w

2026-04-232026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 26w current

Total tracked: 26 weeks across 1 stage run.

LABT among Biotechnology582nd of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…582	LABTLakewood-Amedex Biotherapeutics Inc.	—	—	−72.5%

vs 52W High

—

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 26

1w13w26w

Week 26, proven structure

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

—

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

0.20x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-72.5%

-81.4%

-99.4%

YTD

—

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S—

Wk 26 · Vol 0.20x

2026-10-21S—

Wk 26 · Vol 0.44x

2026-10-20S—

Wk 25 · Vol 0.07x

2026-10-19S—

Wk 25 · Vol 0.06x

2026-10-16S—

Wk 25 · Vol 0.04x

2026-10-15S—

Wk 25 · Vol 0.10x

2026-10-14S—

Wk 25 · Vol 0.09x

2026-10-13S—

Wk 24 · Vol 0.10x

2026-10-12S—

Wk 24 · Vol 0.11x

2026-10-09S—

Wk 24 · Vol 0.08x

2026-10-08S—

Wk 24 · Vol 0.14x

2026-10-07S—

Wk 24 · Vol 6.35x

Moving averages & range

50 DMA

$1.63

200 DMA

—

52W High

—

52W Low

—

5D Low

$0.47

Resistance levels (recent highs)

20d High

$1.67

60d High

$2.76

120d High

$33.00

250d High

—

Next resistance

+240.8%

to 20d High

ROE

-402.8%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.2

Lakewood-Amedex Biotherapeutics: quick answers

Which sector and industry is Lakewood-Amedex Biotherapeutics in?

Lakewood-Amedex Biotherapeutics is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.